AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share
25/05/2026 – Following release of 2025 results and securing of clinical trial insurance policy, Maxim Group reiterates its buy recommendation on AB Science’s stock with a target price of EUR 4.0 per share